Status:
COMPLETED
COVID19 Neurological Manifestation
Lead Sponsor:
University of Pittsburgh
Conditions:
SARS-CoV 2
Neurologic Manifestations
Eligibility:
All Genders
18+ years
Brief Summary
This study is a prospective observational cohort study to document the prevalence and types of neurological manifestations among hospitalized patients with confirmed or suspected novel coronavirus inf...
Detailed Description
This study is a prospective observational cohort study to document the prevalence and types of neurological manifestations among hospitalized patients with confirmed or suspected novel coronavirus inf...
Eligibility Criteria
Inclusion
- Patients greater than or equal to 18 years old
- Admitted with suspected or confirmed COVID19 infection
- Patient exhibiting acute neurological symptoms
Exclusion
- Patients under the age of 18 years old
- Pre-existing, baseline severe neurologic dysfunction including baseline coma/vegetative state, baseline quadriparesis, baseline refractory seizure disorder with frequent breakthrough seizures despite anticonvulsant use
Key Trial Info
Start Date :
April 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 30 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04496128
Start Date
April 13 2020
End Date
May 30 2021
Last Update
August 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261